Axsome Therapeutics (AXSM) Capital Expenditures (2015 - 2026)
Axsome Therapeutics recorded quarterly Capital Expenditures of $121000.0 in Q1 2026, up 70.42% quarter-over-quarter from $71000.0 in Q4 2025, and down 64.2% year-over-year from $338000.0 in Q1 2025.
Axsome Therapeutics' Capital Expenditures history runs 12 years deep, the most recent figure standing at $121000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 64.2% year-over-year to $121000.0; the TTM figure through Mar 2026 stood at $263000.0 (down 48.43% YoY), while the FY2025 annual figure was $480000.0, up 77.78% from the prior year.
- Capital Expenditures came in at $121000.0 for Q1 2026 at Axsome Therapeutics, up from $71000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $371000.0 in Q3 2023 to a low of $7000.0 in Q4 2023.
- A 5-year average of $126764.7 and a median of $90000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 40033.04% in 2022 and tumbled 96.13% in 2023, its largest moves.
- Axsome Therapeutics' Capital Expenditures stood at $181000.0 in 2022, then sank by 96.13% to $7000.0 in 2023, then surged by 328.57% to $30000.0 in 2024, then surged by 136.67% to $71000.0 in 2025, then soared by 70.42% to $121000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $121000.0, $71000.0, and $58000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 121,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 71,000.00 |
| Dec 31, 2025 | 71,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 338,000.00 |
| Mar 31, 2025 | 338,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 371,000.00 |
| Sep 30, 2023 | 371,000.00 |
| Jun 30, 2023 | 133,000.00 |
| Jun 30, 2023 | 133,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 66,000.00 |
| Sep 30, 2022 | 66,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Dec 31, 2021 | 451.00 |
| Dec 31, 2021 | 451.00 |
| Sep 30, 2021 | 258,677.00 |
| Sep 30, 2021 | 258,677.00 |
| Jun 30, 2021 | 18,877.00 |
| Jun 30, 2021 | 18,877.00 |
| Mar 31, 2021 | 29,995.00 |
| Mar 31, 2021 | 29,995.00 |
| Dec 31, 2020 | 20,287.00 |
| Dec 31, 2020 | 20,287.00 |
| Sep 30, 2020 | 14,845.00 |
| Sep 30, 2020 | 14,845.00 |
| Jun 30, 2020 | 1,428.00 |
| Jun 30, 2020 | 1,428.00 |
| Mar 31, 2020 | 9,331.00 |
| Mar 31, 2020 | 9,331.00 |
| Dec 31, 2019 | 1,461.00 |
| Dec 31, 2019 | 1,461.00 |
| Sep 30, 2019 | 3,196.00 |
| Sep 30, 2019 | 3,196.00 |
| Sep 30, 2018 | 8,481.00 |
| Sep 30, 2018 | 8,481.00 |
| Jun 30, 2018 | 9,639.00 |
| Jun 30, 2018 | 9,639.00 |
| Mar 31, 2018 | 14,576.00 |
| Mar 31, 2018 | 14,576.00 |
| Dec 31, 2017 | 1.00 |
| Dec 31, 2017 | 1.00 |
| Sep 30, 2017 | 3,603.00 |
| Sep 30, 2017 | 3,603.00 |
| Jun 30, 2017 | 3,395.00 |
| Jun 30, 2017 | 3,395.00 |
| Mar 31, 2017 | 2,899.00 |
| Mar 31, 2017 | 2,899.00 |
| Dec 31, 2016 | 6,055.00 |
| Dec 31, 2016 | 6,055.00 |
| Sep 30, 2016 | 76,254.00 |
| Sep 30, 2016 | 76,254.00 |
| Jun 30, 2016 | 11,601.00 |
| Jun 30, 2016 | 11,601.00 |
| Mar 31, 2016 | 10,651.00 |
| Mar 31, 2016 | 10,651.00 |
| Dec 31, 2015 | 4,112.00 |
| Dec 31, 2015 | 4,112.00 |
| Sep 30, 2015 | 4,407.00 |
| Sep 30, 2015 | 4,407.00 |
| Jun 30, 2015 | 1,420.00 |
| Jun 30, 2015 | 1,420.00 |
| Mar 31, 2015 | 10,256.00 |
| Mar 31, 2015 | 10,256.00 |